Radiotherapy in palliative treatment of painful bone metastases

Nielsen OS, Munro AJ, Tannock IF. Bone metastases: Pathophysiology and management policy. J Clin Oncol 1991; 9: 509-24.10.1200/JCO.1991.9.3.509Search in Google Scholar

Cleeland CS. Cancer-related symptoms. Sem Radiat Oncol 2000; 10: 175-90.10.1053/srao.2000.6590Search in Google Scholar

Coleman RE. Bisphosphonates: clinical experience. Oncologist 2004; 9(Suppl 4): 14-27.10.1634/theoncologist.9-90004-14Search in Google Scholar

Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Raja Abdullah RSA. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach. Radiol Oncol 2009; 43: 180-6.10.2478/v10019-009-0023-ySearch in Google Scholar

Stoll BA. Natural history, prognosis, and staging of bone metastases. In: Szoll BA, Parboo S, editors. Bone metastases: monitoring and treatment. New York: Raven; 1983. p. 1-20.Search in Google Scholar

Chow E, Finkelstein JA, Coleman RE. Metastatic cancer to the bone. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer, principles and practice of oncology. Vol 2. 8th edition. Philadelphia: Wolters Kluver, Lippincott; 2008. p. 2510-22.Search in Google Scholar

Debevec L, Debeljak A, Eržen J, Kovač V, Kern I. Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia. Radiol Oncol 2005; 39: 115-21.Search in Google Scholar

Lote K, Walloe A, Bjersand A. Bone metastasis. Prognosis, diagnosis and treatment. Acta Radiol Oncol 1986; 25: 227-32.10.3109/02841868609136410Search in Google Scholar

Rajer M, Kovač V. Malignant spinal cord compression. Radiol Oncol 2008; 42: 23-31.10.2478/v10019-007-0035-4Search in Google Scholar

Debois JM. TxNxM1. The anatomy and clinic of metastatic cancer. Dordrecht: Kluwer Academic Publishers; 2002.Search in Google Scholar

Jacobs SC. Spread of prostatic cancer to bone. Urology 1983; 21: 337-44.10.1016/0090-4295(83)90147-4Search in Google Scholar

Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997; 69: 1-18.10.1016/S0304-3959(96)03267-8Search in Google Scholar

Strojan P, Debevec M, Kovač V. Superior sulcus tumor (SST): management at the Institute of Oncology in Ljubljana, Slovenia, 1981-1994. Lung cancer 1997; 17: 249-59.10.1016/S0169-5002(97)00659-4Search in Google Scholar

Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics an impact in patients with cancer pain. Pain 1999; 81: 129-34.10.1016/S0304-3959(99)00006-8Search in Google Scholar

Zucali R. Radiotherapy of bone lesions. In: Gerattini S, editor. Bone resorption, metastasis, and diphosphonates. New York: Raven; 1985. p. 117-26.Search in Google Scholar

Pandit-Taskar N, Batraki M, Divgi CR. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 2004; 45: 1358-65.Search in Google Scholar

Mercadante S, Fulfaro F. Management of painful bone metastases. Curr Opin Oncol 2007; 19: 308-14.10.1097/CCO.0b013e3281214400Search in Google Scholar

Dy SM, Asch SM, Naeim A, Sanati H, Walling A, Lorenz KA. Evidence-based standards for cancer pain management. J Clin Oncol 2008; 26: 3879-85.10.1200/JCO.2007.15.9517Search in Google Scholar

Hoskin PJ. Opioids in context: relieving the pain of cancer. The role of comprehensive cancer management. Palliat Med 2008; 22: 303-9.10.1177/0269216308089307Search in Google Scholar

Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone matastasis. Int J Dev Biol 2004; 48: 599-606.10.1387/ijdb.041817lvSearch in Google Scholar

Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of randomised trials. Clin Oncol 2003; 15: 345-52.10.1016/S0936-6555(03)00113-4Search in Google Scholar

Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dosefractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003; 55: 594-605.10.1016/S0360-3016(02)04147-0Search in Google Scholar

Loblaw DA, Wu JS, Kirkbride P, Panzarella T, Smith K, Aslanidis J, et al. Pain flare in patients with bone metastases after palliative radiotherapy-a nested randomized control trial. Support Care Cancer 2007; 15: 451-5.10.1007/s00520-006-0166-ySearch in Google Scholar

Hird A, Chow E, Zhang L, Wong R, Wu J, Sinclair E, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys 2009; 75: 193-7.10.1016/j.ijrobp.2008.10.044Search in Google Scholar

Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction shedule over 12 months of patients follow- up. Radiother Oncol 1999; 52: 111-21.10.1016/S0167-8140(99)00097-3Search in Google Scholar

Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, de Dios NR, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 2008; 89: 150-5.10.1016/j.radonc.2008.05.01818556080Search in Google Scholar

Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997; 45: 109-16.10.1016/S0167-8140(97)00101-1Search in Google Scholar

Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of shortversus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97: 798-804.10.1093/jnci/dji139Search in Google Scholar

Hirokawa Y, Wadasaki K, Kashiwado K, Kagemoto M, Katsuta S, Honke Y, et al. A multi-institutional prospective randomized study of radiation therapy of bone metastases. Nippon Igaku Hoshasen Gakkai Zasshi 1988; 48: 1425-31.Search in Google Scholar

Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 1992; 23: 74-8.10.1016/0167-8140(92)90338-USearch in Google Scholar

Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 1998; 42: 161-7.10.1016/S0360-3016(98)00174-6Search in Google Scholar

Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol 2006; 79: 278-84.10.1016/j.radonc.2006.05.006Search in Google Scholar

Kirkbride P, Warde PR, Panzarella T, Aslanidis J, McKenzie M, Sun A. A Randomised trial comparing the efficacy of a single radiation fraction with fractionated radiation therapy in the palliation of skeletal metastases. Int J Radiat Oncol Biol Phys 2000; 48(Suppl 3): 185.10.1016/S0360-3016(00)80164-9Search in Google Scholar

Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 1999; 175: 500-8.10.1007/s000660050061Search in Google Scholar

Mañas A, Casas F, Ciria JP, López C, Sáez J, Palacios A, et al. Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases. Clin Transl Oncol 2008; 10: 281-7.10.1007/s12094-008-0198-5Search in Google Scholar

Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 1998; 47: 233-40.10.1016/S0167-8140(98)00011-5Search in Google Scholar

Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986; 6: 247-55.10.1016/S0167-8140(86)80191-8Search in Google Scholar

Roos DE, Turner SL, O'Brien PC, Smith JG, Spry NA, Burmeister BH, et al, Trans-Tasman Radiation Oncology Group, TROG 96.05. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005; 75: 54-63.10.1016/j.radonc.2004.09.017Search in Google Scholar

Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994; 31: 33-40.10.1016/0167-8140(94)90411-1Search in Google Scholar

Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol 1995; 34: 179-84.10.1016/0167-8140(95)01520-QSearch in Google Scholar

Steenland E, Leer JW, van Houwelingen H, Post Wj, van den Hout WB, Kievit J, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999; 52: 101-9.10.1016/S0167-8140(99)00110-3Search in Google Scholar

Tong D, Gillick, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer 1982; 50: 893-9.10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-YSearch in Google Scholar

Chow E, Lutz S, Beyene J. A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases. Int J Radiat Biol Phys 2003; 55: 565-7.10.1016/S0360-3016(02)04148-2Search in Google Scholar

Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004; 51: 334-40.Search in Google Scholar

Jeremic B, Shibamoto Y, Igrutovic I. Single 4 Gy reirradiation for painful bone metastasis following single fraction radiotherapy. Radiother Oncol 1999; 52: 123-7.10.1016/S0167-8140(99)00108-5Search in Google Scholar

Stanković M, Marić D, Ilić M, Veselinović I, Ninković S, Sečen S. Abscess of C1/C2 cervical vertebrae - errors in diagnosis and therapy. Radiol Oncol 2009; 43: 240-6.10.2478/v10019-009-0027-7Search in Google Scholar

Haddad P, Wong RK, Pond GR, Soban F, Williams D, McLean M, et al. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review. Clin Oncol (R Coll Radiol) 2005; 17: 430-4.10.1016/j.clon.2005.03.012Search in Google Scholar

van den Hout WB, van der Linden YM, Steenland E, Wiggenraad RG, Kievit J, de Haes H, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 2003; 95: 222-9.10.1093/jnci/95.3.222Search in Google Scholar

Pollicino CA, Turner SL, Roos DE, O'Brien PC. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiother Oncol 2005; 76: 264-9.10.1016/j.radonc.2005.07.003Search in Google Scholar

Salazar OM, Rubin P, Keller B, Scarantino C. Systemic (half-body) radiation therapy: Response and toxicity. Int J Radiat Oncol Biol Phys 1978; 4: 937-50.10.1016/0360-3016(78)90003-2Search in Google Scholar

Salazar OM, Sandhu T, da Motta NW, Perez Escutia MA, Lanzos-Gonzales E, Mouelle-Sone A, et al. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: A randomized phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 2001; 50: 765-75.10.1016/S0360-3016(01)01495-XSearch in Google Scholar

Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 1986; 58: 29-36.10.1002/1097-0142(19860701)58:1<29::AID-CNCR2820580107>3.0.CO;2-2Search in Google Scholar

Salazar OM, daMotta NW, Bridgman SM, Cardiges NM, Slawson RG. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: Comparison with single dose. Int J Radiat Oncol Biol Phys 1996; 36: 49-60.10.1016/S0360-3016(96)00248-9Search in Google Scholar

Lewington VJ. Bone-seeking radionuclides for therapy. J Nucl Med 2005; 46: 38-47.Search in Google Scholar

Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1993; 25: 805-13.10.1016/0360-3016(93)90309-JSearch in Google Scholar

Piffanelli A, Dafermou A, Giganti M, Colamussi P, Pizzocaro C, Bestagno M, et al. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. Q. J Nucl Med 2001; 45: 100-7.Search in Google Scholar

Roqué M, Martinez MJ, Alonso P, Catal E, Garcia JL, Ferrandiz M. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev 2003; 4: CD003347.10.1002/14651858.CD003223Search in Google Scholar

Kampen WU, Fischer M. Pain palliation using unsealed radionuclides. Schmerz 2008; 22: 699-705.Search in Google Scholar

Gkialas I, Iordanidou L, Galanakis I, Giannopoulos S. The use of radioisotopes for palliation of metastatic bone pain. J BUON 2008; 13: 177-83.Search in Google Scholar

Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol 2009; 16: 140-6.10.1245/s10434-008-0011-2Search in Google Scholar

Tseng YY, Lo YL, Chen LH, Lai PL, Yang ST. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor. Surg Neurol 2008; 70(Suppl 1): S78-83.10.1016/j.surneu.2008.08.078Search in Google Scholar

Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, et al. A systematic review of the role of bisphosphonates in metastatic disease. Health Technol Assess 2004; 8: 1-176.10.3310/hta8040Search in Google Scholar

Fleisch H. Development of bisphosphonates. Breast Cancer Res 2002; 4: 30-4.10.1186/bcr41413871311879557Search in Google Scholar

Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 2000; 60: 2949-54.Search in Google Scholar

Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 2000; 15: 2211-21.10.1359/jbmr.2000.15.11.221111092402Search in Google Scholar

Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008; 19: 420-32.10.1093/annonc/mdm44217906299Search in Google Scholar

Green JR, Muller K, Jaeggi KA: Preclinical pharmacology of CGP 42'446, a new potent, heterocyclic bisphosphonate compound. J Bone Miner Res 1994; 9: 745-51.10.1002/jbmr.56500905218053405Search in Google Scholar

Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11: 59-65.10.1200/JCO.1993.11.1.598418243Search in Google Scholar

Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev 2005; 3: CD003474.10.1002/14651858.CD003474.pub216034900Search in Google Scholar

Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 2003; 98: 1735-44.10.1002/cncr.1170114534891Search in Google Scholar

Neville-Webbe HL, Evans CA, Coleman RE, Holen I. Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro. Tumour Biol 2006; 27: 92-103.10.1159/00009248916582586Search in Google Scholar

Vogt U, Bielawski KP, Bosse U, Schlotter CM. Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid. Oncol Rep 2004; 12: 1109-14.10.3892/or.12.5.1109Search in Google Scholar

Journé F, Magné N, Chaboteaux C, Kinnaert E, Bauss F, Body JJ. Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines. Clin Exp Metastasis 2006; 23: 135-47.10.1007/s10585-006-9025-y16912915Search in Google Scholar

Chang JW, Hsieh JJ, Shen YC, Yeh KY, Wang CH, Li YY, Hsu T. Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells. Cancer Lett 2009; 278: 17-26.10.1016/j.canlet.2008.12.01919233551Search in Google Scholar